Nobuki Furubayashi
9PUBLICATIONS
4CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (9)
Sort by Publication Date:
|Dec 30, 2025
Perioperative Chemotherapy in Bladder and Upper Tract Urothelial Carcinoma: Outcomes by Nodal Status and Lymphovascular Invasion.Nobuki Furubayashi, Jiro Tsujita, Azusa Takayama
|Oct 01, 2025
Clinical Outcomes of Avelumab Maintenance Following Full-Dose, Reduced-Dose Cisplatin, or Carboplatin-Based Chemotherapy in Advanced Urothelial Carcinoma.Nobuki Furubayashi, Jiro Tsujita, Azusa Takayama
|Aug 14, 2025
Avelumab Maintenance Therapy for Advanced Urothelial Carcinoma with Low Tumor Burden.Nobuki Furubayashi, Jiro Tsujita, Azusa Takayama
|Nov 17, 2022
The Eosinophil Changes, Efficacy and Safety of Pembrolizumab in Advanced Urothelial Carcinoma Patients with an Older Age and a Poor Performance Status.Nobuki Furubayashi, Akinori Minato, Takahito Negishi
|May 10, 2022
Association Between Immune-Related Adverse Events and Efficacy and Changes in the Relative Eosinophil Count Among Patients with Advanced Urothelial Carcinoma Treated by Pembrolizumab.Nobuki Furubayashi, Akinori Minato, Takahito Negishi
Pageof 2